Medication
Ended Awarded
- Contract number
- 36C24621N0739
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,304
Award facts
- Contract value 100% obligated
- $10,303.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
On April 7, 2021, the Department of Veterans Affairs Veterans Integrated Service Network 6 awarded a delivery order contract to Otsuka America Pharmaceutical Inc. for medication with a ceiling value of $10,303.50. This firm fixed-price delivery order, which is not set-aside designated, is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and requires performance at the contractor's facility in Potomac, Maryland, with an ultimate completion date of April 30, 2021. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, specializes in developing and distributing specialty pharmaceuticals, with a particular focus on providing complex medications to the VA healthcare system.
This delivery order is one of multiple task orders issued under Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle with the VA, specifically an $83.3 million Blanket Purchase Agreement for Jynarque (tolvaptan), a specialty medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The company maintains significant established relationships with the VA across multiple Integrated Service Networks and holds an additional $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. These contracts support the VA's mission of providing specialized pharmaceutical treatments to veterans nationwide through streamlined procurement mechanisms.
Quick answers
Who was awarded contract 36C24621N0739?
36C24621N0739 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on April 7, 2021.
How much is contract 36C24621N0739 worth?
The government has obligated $10,304 on 36C24621N0739.
Is contract 36C24621N0739 an order under another contract?
Yes. 36C24621N0739 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621N0739 competed?
The extent of competition for 36C24621N0739 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award